- A Transgenic plants
- B Monoclonal antibodies
- C Recombinant insulin
- D PCR products
Correct answer: B. Monoclonal antibodies
Explanation: Hybridoma technology fuses antibody-producing B cells with cancer cells (myeloma) to create immortal hybridomas that produce monoclonal antibodies.
Concept context
Recombinant DNA, GMOs, PCR, CRISPR, and biotechnology applications. Growing importance in NEET.
Read the full Biotechnology: Principles and Processes notes →